The science of medical weight loss
The science of medical weight loss
Understand appetite biology, metabolic adaptation and evidence-based medications used in modern medical weight loss.
Obesity is biologically regulated
Body weight is influenced by genetics, appetite signaling, food environment, sleep, medications, endocrine conditions, mental health, muscle, activity and adaptive changes in energy expenditure. After weight loss, hunger hormones and metabolic adaptation can favor regain. This biology explains why “eat less and move more” is incomplete advice and why chronic treatment may be appropriate.
Major treatment mechanisms
Energy intake and satiety
Nutrition structure and medications can reduce energy intake while maintaining adequate protein and micronutrients.
Incretin pathways
GLP-1 and GIP pathways influence appetite, insulin secretion, glucagon signaling and gastric emptying.
Food absorption
Orlistat reduces absorption of dietary fat through intestinal lipase inhibition.
Central appetite pathways
Phentermine/topiramate and naltrexone/bupropion act through different brain pathways and have distinct contraindications.
Current FDA-approved options
| Class | Examples | Clinical perspective |
|---|---|---|
| GLP-1 receptor agonists | Wegovy injection/tablets, Wegovy HD, Saxenda | Product-specific dosing, indications and warnings apply |
| Dual GIP/GLP-1 agonist | Zepbound | Substantial average loss; also approved for certain adults with obesity and moderate-to-severe OSA |
| Oral nonpeptide GLP-1 | Foundayo | FDA-approved oral option for eligible adults as of 2026 |
| Combination tablets | Qsymia, Contrave | Useful alternatives with cardiovascular, neurologic, reproductive or interaction considerations |
| Lipase inhibitor | Orlistat | Non-systemic mechanism with GI and nutrient-absorption considerations |
Beyond the number on the scale
- Waist and visceral-fat reduction
- Blood pressure, glucose and lipid improvement
- Sleep-apnea severity and daytime function
- Fatty liver and metabolic risk
- Mobility, osteoarthritis symptoms and quality of life
- Preservation of strength, muscle and bone
How W8MD can help
W8MD Weight Loss, Sleep & MedSpa provides physician-supervised care from active offices in Brooklyn, New York and Northeast Philadelphia, serving patients from greater New York City, New Jersey and the greater Philadelphia region. Telehealth may be available when clinically and legally appropriate.
W8MD accepts many insurance plans for visits. When a plan covers an FDA-approved medication and the patient meets its criteria, W8MD can submit prior-authorization documentation. The insurer determines coverage and approval.
W8MD translates obesity science into an individualized plan rather than matching everyone to the same injection. Treatment decisions account for comorbidities, pregnancy plans, sleep, previous response, insurance and long-term access.
W8MD regional resources: Visit NYC Medical Weight Loss and Philadelphia Medical Weight Loss. For encyclopedia background, see obesity and weight loss at WikiMD.
Frequently asked questions
Is obesity only caused by genetics?
No. Genetics interact with biology, environment, behavior, medicines and disease.
Do medications permanently reset metabolism?
They treat active biological pathways; benefits may diminish after discontinuation.
Which medication is scientifically best?
There is no universal best choice. Effectiveness must be balanced against safety, indication, tolerability and access.
Evidence and authoritative sources
Request a W8MD consultation
W8MD Weight Loss, Sleep & MedSpa provides physician-supervised care in Brooklyn, New York and Northeast Philadelphia. Telehealth may be available for eligible patients based on location and applicable requirements.
Contact W8MD
